Ebony PTA .014 RX Peripheral Dilatation Catheter
510(k) K152230
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK152230 | Date3 Sep 2015 | StatusActive |
Recalls
-
- Terminated Z-1362-2016
Product may kink during use rendering the product unusable.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- Ebony PTA .014 RX Pheripheral Dilatation Catheter
- 510(k) Number
- FDA Product Code
- LIT
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.1250
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Ebony PTA .014 RX Peripheral Dilatation Catheter is a percutaneous transluminal angioplasty (PTA) catheter designed for the dilatation of peripheral arterial lesions. It is intended for use in the iliac, femoral, popliteal, infra-popliteal, and renal arteries to restore blood flow by mechanically widening narrowed or obstructed segments. Constructed for precision, this catheter features a .014-inch outer diameter, enabling navigation through smaller vessels while delivering controlled dilation via an inflatable balloon.
This device is supplied as a single-use, non-sterile catheter requiring terminal sterilization prior to use. It is classified as a Class II medical device under FDA regulations (870.1250) and has received FDA 510(k) clearance (K152230) as substantially equivalent to predicate devices. The catheter is available in various balloon sizes and lengths, including diameters up to 1.5 mm and lengths up to 200 mm, to accommodate different clinical scenarios. Compatibility with imaging modalities, including MRI safety considerations, is not specified in the regulatory data.
Other devices from Natec Medical Ltd
Questions
AI-generated answers, 1 Oct 2026
What is the Ebony PTA .014 RX Peripheral Dilatation Catheter used for?
This catheter is designed specifically for percutaneous transluminal angioplasty (PTA) to mechanically widen narrowed or obstructed segments in peripheral arteries. It is intended for use in the iliac, femoral, popliteal, infra-popliteal, and renal arteries to restore blood flow by controlled dilation via an inflatable balloon. Its .014-inch outer diameter allows navigation through smaller vessels, making it suitable for precise interventions in tight or complex anatomical areas.
How is the Ebony PTA .014 RX catheter supplied, and what sterilization is required?
The catheter is supplied as a single-use, non-sterile device. Terminal sterilization must be performed prior to use, as it is not pre-sterilized by the manufacturer. This ensures safety and efficacy for each procedure, as single-use devices are not intended for reuse.
What balloon sizes and lengths are available for the Ebony PTA .014 RX catheter?
The catheter is available in various balloon sizes and lengths to accommodate different clinical scenarios. Balloon diameters range up to 1.5 mm, and lengths extend up to 200 mm. These options allow clinicians to select the appropriate size for the specific arterial segment being treated, ensuring optimal dilation and minimal trauma to the vessel wall.
Is the Ebony PTA .014 RX catheter compatible with imaging modalities like MRI?
The regulatory data for this device does not specify compatibility with imaging modalities such as MRI. Clinicians should verify compatibility with their specific imaging equipment and protocols before use, particularly if MRI safety is a concern in the procedure.
What regulatory clearance does the Ebony PTA .014 RX catheter hold, and how is it classified?
The Ebony PTA .014 RX Peripheral Dilatation Catheter is classified as a Class II medical device under FDA regulations (870.1250). It has received FDA 510(k) clearance (K152230) as substantially equivalent to predicate devices, indicating it meets the necessary safety and effectiveness standards for marketing in the United States.